The United States Securities and Exchange Commission (SEC) charged a hedge fund adviser and his investment advisory firm with illegally profiting from a scheme to drive down the price of San Diego-based Ligand Pharmaceuticals, reaping more than $1.3 million of gains for the adviser and the hedge fund.

According to a press release from the federal government agen